Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System.
Ruggiero R, Balzano N, Nicoletti MM, di Mauro G, Fraenza F, Campitiello MR, Rossi F, Capuano A. Ruggiero R, et al. Among authors: di mauro g. Pharmaceuticals (Basel). 2024 Mar 19;17(3):394. doi: 10.3390/ph17030394. Pharmaceuticals (Basel). 2024. PMID: 38543180 Free PMC article.
Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study.
Scavone C, Sportiello L, Sullo MG, Ferrajolo C, Ruggiero R, Sessa M, Berrino PM, di Mauro G, Berrino L, Rossi F, Rafaniello C, Capuano A; BIO-Cam Group. Scavone C, et al. Among authors: di mauro g. Front Pharmacol. 2017 Sep 6;8:607. doi: 10.3389/fphar.2017.00607. eCollection 2017. Front Pharmacol. 2017. PMID: 28932193 Free PMC article.
Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors.
Sessa M, di Mauro G, Mascolo A, Rafaniello C, Sportiello L, Scavone C, Capuano A. Sessa M, et al. Among authors: di mauro g. Front Pharmacol. 2018 Jun 12;9:611. doi: 10.3389/fphar.2018.00611. eCollection 2018. Front Pharmacol. 2018. PMID: 29946258 Free PMC article.
The European clinical trials regulation (No 536/2014): changes and challenges.
Scavone C, di Mauro G, Pietropaolo M, Alfano R, Berrino L, Rossi F, Tomino C, Capuano A. Scavone C, et al. Among authors: di mauro g. Expert Rev Clin Pharmacol. 2019 Nov;12(11):1027-1032. doi: 10.1080/17512433.2019.1680282. Epub 2019 Oct 21. Expert Rev Clin Pharmacol. 2019. PMID: 31608706 Review.
154 results